Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection
Clinical trial NCT01718834 · UNKNOWN
Trial details
- NCT number
- NCT01718834
- Sponsor
- National Liver Institute, Egypt
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-03-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.